Australia markets close in 5 hours 23 minutes

IDEX Biometrics ASA (IDBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
19.25-2.45 (-11.29%)
At close: 03:47PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 400.15M
Enterprise value 387.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)136.70
Price/book (mrq)21.95
Enterprise value/revenue 146.22
Enterprise value/EBITDA -14.27

Trading information

Stock price history

Beta (5Y monthly) 2.22
52-week change 3-23.40%
S&P500 52-week change 314.07%
52-week high 332.82
52-week low 316.14
50-day moving average 327.58
200-day moving average 322.61

Share statistics

Avg vol (3-month) 3848
Avg vol (10-day) 31.04k
Shares outstanding 513.47M
Implied shares outstanding 6N/A
Float 88.54M
% held by insiders 10.00%
% held by institutions 10.01%
Shares short (30 Dec 2021) 41.34k
Short ratio (30 Dec 2021) 43.76
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 40.01%
Shares short (prior month 29 Nov 2021) 42.58k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,115.16%

Management effectiveness

Return on assets (ttm)-105.33%
Return on equity (ttm)-205.43%

Income statement

Revenue (ttm)2.65M
Revenue per share (ttm)0.22
Quarterly revenue growth (yoy)195.20%
Gross profit (ttm)820k
EBITDA -28.61M
Net income avi to common (ttm)-29.48M
Diluted EPS (ttm)-2.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.94M
Total cash per share (mrq)1.05
Total debt (mrq)405k
Total debt/equity (mrq)2.17
Current ratio (mrq)6.36
Book value per share (mrq)1.50

Cash flow statement

Operating cash flow (ttm)-26.2M
Levered free cash flow (ttm)-15.92M